Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 3Colorectal Neoplasms 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Sedentary Behavior 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Obesity, Abdominal 1Neoplasms 1Lymphoma 1Liver Neoplasms 1Invasive Breast Carcinoma 1High-Frequency Microsatellite Instability 1Head and Neck Carcinoma 1Fatigue 1Fallopian Tube Neoplasms 1Carcinoma, Hepatocellular 1Breast Carcinoma In Situ 1

Interventions

Cyclophosphamide 444Rituximab 401Etoposide 224Vincristine 215Doxorubicin 201Filgrastim 200Prednisone 176Cytarabine 159Radiotherapy 152fludarabine phosphate 147Methotrexate 137Peripheral Blood Stem Cell Transplantation 129Melphalan 127fludarabine 115Busulfan 99Dexamethasone 93Tacrolimus 75Carmustine 74Granulocyte Colony-Stimulating Factor 73Mycophenolic Acid 71Gemcitabine 66Bortezomib 65Antilymphocyte Serum 65Whole-Body Irradiation 62Cyclosporine 62Bendamustine Hydrochloride 62Lenalidomide 60Ifosfamide 58sargramostim 51Methylprednisolone 49

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Lymphoma × Monitoring, Physiologic × Clear all
NCT03574012 2024-01-23

SmART Heart: Study of mHealth Apps to Reduce Cancer-Treatment Effects on the Heart

Fred Hutchinson Cancer Center

Phase NA Completed
41 enrolled
Lymphoid

Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡